Novel Smoking Cessation Drug for Schizophrenia

Clinical trial NCT02230384 · COMPLETED

Trial details

NCT number: NCT02230384
Sponsor: K.N. Roy Chengappa
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Smoking Cessation

Start date: 2014-09-01
Primary completion: 2016-12-16
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.